Drug Delivery Infusion System Market Size, Share, Industry, Forecast and outlook (2023-2030)

Global Drug Delivery Infusion Systems Market is segmented By Product Type (Volumetric pumps, Syringe Infusion Systems, Ambulatory Infusion Systems, Implantable Infusion Systems, Insulin Infusion Pumps, Enteral Infusion Systems), By Application (Oncology/Chemotherapy, Diabetes, Analgesia, Nutrition, Haematology, Paediatrics), By End User (Hospital, Ambulatory Surgery Centers, Homecare Settings), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2023-2030

Drug Delivery Infusion Systems Market Overview

The Global Drug Delivery Infusion System Market is expected to grow at a CAGR of 14.3% during the forecasting period (2023-2030). Drug Delivery Infusion Systems are used to administer medications and fluids to critically ill patients by infusion. The global Drug Delivery Infusion Systems market was estimated at USD 9 billion in 2017. The market is driven by the increased prevalence of chronic diseases such as cancer and diabetes coupled with rising demand for improved patient care. As a result, the market will witness increased usage across different therapeutic indications over the forecast period. However, factors concerning patient safety and improper infusion leading to severe consequences will hamper the growth of the market.

Drug Delivery Infusion Systems Market SUMMARY AND SCOPE

Drug Delivery Infusion Systems Market Segmentation Analysis

• The global Drug Delivery Infusion Systems market report segments the market by product type, by application, by the end-user, and by region. Based on product, the market is segmented into volume pumps, enteral pumps, syringe pumps, insulin pumps, ambulatory pumps, implantable pumps. Volumetric pumps were the major contributor to the market in 2017. Based on what these devices are being used and in which therapeutic area, the market is segmented into diabetes, oncology, analgesia, nutrition, hematology, and pediatrics.

• Regionally, the market is segmented into five major regions, namely North America, South America, Europe, Asia Pacific, and RoW. North America accounted for the largest market share in the global Drug Delivery Infusion Systems market in 2017 owing to positive government regulations and reimbursement policies.

• Asia Pacific region recorded the highest growth rate because of rising healthcare expenditure and increasing patient awareness. The report also profiles the following companies in the Drug Delivery Infusion Systems market – Acromed AG, B. Braun Melsungen AG, Baxter International, Becton Dickinson and Company, Caesarea Medical Electronics Ltd., Flowonix Medical Inc., Fresenius Kabi, IRADIMED CORPORATION, Medtronic, Terumo Corporation, ICU Medical, Inc. and Insulet Corporation.

Key Segments Covered

By Product Type

• Volumetric pumps

• Syringe Infusion Systems

• Ambulatory Infusion Systems

• Implantable Infusion Systems

• Insulin Infusion pumps

• Enteral Infusion Systems

By Application

• Oncology/Chemotherapy

• Diabetes

• Analgesia

• Nutrition

• Haematology

• Paediatrics

By End-User

• Hospital

• Ambulatory Surgical Centre

• Home care setting

By Region

• Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific)

• Europe (Germany, France, The UK, Italy, Spain, Rest of Europe)

• North America (The USA, Canada, Mexico)

• South America (Brazil, Argentina, Rest of South America)

• Rest of the World